Gene: HECA
Official Full Name: hdc homolog, cell cycle regulatorprovided by HGNC
Gene Summary: This gene encodes the homolog of the Drosophila headcase protein, a highly basic, cytoplasmic protein that regulates the re-entry of imaginal cells into the mitotic cycle during adult morphogenesis. In Drosophila, the encoded protein also inhibits terminal branching of neighboring cells during tracheal development. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22270 | HECA Knockout cell line (HeLa) | Human | HECA | 1:3~1:6 | Negative | Online Inquiry |
KO22271 | HECA Knockout cell line (HCT 116) | Human | HECA | 1:2~1:4 | Negative | Online Inquiry |
KO22272 | HECA Knockout cell line (HEK293) | Human | HECA | 1:3~1:6 | Negative | Online Inquiry |
KO22273 | HECA Knockout cell line (A549) | Human | HECA | 1:3~1:4 | Negative | Online Inquiry |
HECA Gene Knockout Cell Lines are advanced biological tools designed to facilitate the investigation of gene function and assess the effects of gene inactivation on cellular processes. These specialized cell lines are engineered to lack specific genes through targeted CRISPR/Cas9 genome editing technology, providing researchers with potent models to study gene expression, regulation, and phenotypic outcomes in a controlled environment.
The key function of HECA Gene Knockout Cell Lines lies in their ability to precisely disrupt the targeted genes, allowing for a comprehensive analysis of the resulting cellular pathways and biological mechanisms. This gene disruption can elucidate the roles of essential genes in various cellular contexts, including growth, differentiation, and response to therapeutic agents. Researchers utilize these cell lines to perform functional assays, drug screening, and pathway analysis, leading to significant contributions to knowledge in fields such as genomics, cancer research, and regenerative medicine.
The scientific importance of HECA Gene Knockout Cell Lines cannot be overstated; they are invaluable in providing insights into gene function and its implications in disease states. In clinical research, these cell lines aid in the development of novel therapies and biomarkers by enabling the identification of gene targets for intervention. Their application spans from basic science to translational medicine, reinforcing their standing as critical resources in the life sciences.
What sets HECA Gene Knockout Cell Lines apart from alternatives is their high specificity and reproducibility, thoroughly validated using both genetic and phenotypic characterization methods. Additionally, they are developed with stringent quality controls to ensure consistent performance, leading to trustworthy results in experimental settings.
The value of HECA Gene Knockout Cell Lines extends to researchers and clinicians eager to advance their projects with reliable models that significantly amplify the understanding of complex biological phenomena. These cell lines empower scientists to make discoveries that could shape future therapeutic strategies and contribute to precision medicine.
At our company, we pride ourselves on our commitment to high standards of scientific rigor and innovation. Our expertise in cellular models and genome editing technologies underscores our dedication to providing researchers with the tools necessary to push the boundaries of biological research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.